天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
Shanghai Star Pharmaceutical Chemical Technology Co., Ltd.
Firmenname:
Shanghai Star Pharmaceutical Chemical Technology Co., Ltd.
Telefon:
021-58521787
E-Mail:
starpharmsh@gmail.com
Nationalit?t:
China
URL:
www.starpharm-sh.com
Produkte insgesamt:
208
1
2
3
Produktkatalog
Argireline
616204-22-9
C34H60N14O12S
Rosuvastatin methyl ester
147118-40-9
C23H30FN3O6S
4-Chloromethyl-5- meth-yl-1,3-dioxol- 2-one
4-Chlormethyl-5-methyl-1,3-dioxol-2-on
80841-78-7
C5H5ClO3
Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl- imidazole-5- carboxylate
144689-93-0
C12H20N2O3
Methyl 4'-bromomethyl biphenyl-2-carboxylate
114772-38-2
C15H13BrO2
2-n-Propyl-4-methyl-6-(1-methylbenzimi- dazole-2-yl)benz- imidazole
152628-02-9
C19H20N4
Valsartan methyl ester
137863-17-3
C25H31N5O3
Rabamipide Na
Dapoxetine free base
119356-77-3
C21H23NO
Tadanafil P-1
171489-59-1
C22H19ClN2O5
Dantrolene free base
85008-71-5
C14H10N4O5
Varenicline free base
249296-44-4
C13H13N3
N-(4-cyanophenyl)- glycine
42288-26-6
C9H8N2O2
Ethyl N-[3-amino-4-(methylamino)benzoyl]-N- pyridin-2-yl-beta- alaninate
212322-56-0
C18H22N4O3
Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1- methyl-1H-benz- imidazol-5-yl)- carbonyl]-N-pyridin- 2-yl-beta-alaninate
211915-84-3
C27H26N6O3
(S)-2,3-Dimethyl-3-(( triethylsilyl)oxy)butan-1-ol
957997-83-0
C12H28O2Si
(S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol
1217719-34-0
C8H18O3
(R)-(2,3-dimethyl-3-(( triethylsilyl) oxy)butyl)- diphenylphosphine oxide
1227926-70-6
C24H37O2PSi
(R)-(2,3-dimethyl-3- butyl)diphenyl phosphineoxide
C18H23OP
(2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
215509-33-4
C19H38O2Si
(1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy methoxy)-5,6-dimethylhept-3-en-2-yl)-7a- methylhexahydro- 1H-inden-4(2H)-one
100858-26-2
C21H36O3
(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one
950586-26-2
C25H46O2Si
2-((3R,5R)-3,5-bis(( tert-butyldimethyl silyl)-oxy) cyclohexylidene) ethanol
139356-37-9
C20H42O3Si2
(2-((3R,5R)-3,5-bis(( tert-butyldimethyl- silyl)oxy)cyclohexyl- idene)ethyl)diphenylphosphine oxide
139356-39-1
C32H51O3PSi2
ATB-1
1262414-96-9
C10H13FO
ATB-4
237761-77-2
C8H5BrClF3
Diallyl bisphenol A
4,4'-Isopropylidenbis[2-allylphenol]
1745-89-7
C21H24O2
5,6-Dihydroxyindole
3131-52-0
C8H7NO2
5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid
4790-08-3
C9H7NO4
Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate
10131-14-3
C10H9NO4
2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole
437757-21-6
C11H11NO2
(E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate
2187481-85-0
C13H14O4
Cis-Sertraline-D-Madenlic acid
Sitagliptin impurity 1~5
1217809-78-3
C10H11ClF3NO2
Methyl caffeate
67667-67-8
C10H10O4
Quinic acid
1,3,4,5-Tetrahydroxycyclohexancarbonsure
77-95-2
C7H12O6
Phenethyl caffeate
104594-70-9
C17H16O4
ATB-9
875444-10-3
C12H9F6NO2
Caffeic acid
3,4-Dihydroxyzimtsure
331-39-5
C9H8O4
Silodocin P-1 oxalate
Landiolol impurity 1
1253907-85-5
C25H40ClN3O8
Landiolol impurity 2
1253907-81-1
C25H40ClN3O8
Landiolol impurity 3
1253907-83-3
C25H40ClN3O8
Dabigatran amidine HCl
211914-50-5
Indobufen impurity 2
36691-02-8
C20H21NO3
Indobufen impurity 3
203313-55-7
C18H19NO4
Sarpogrelate HCl
125926-17-2
C24H31NO6
BP984
135261-74-4
C20H28ClNO3
Crisaborole impurity 1
906673-43-6
C14H11BO5
Crisaborole impurity 2
1187188-59-5
C14H12BNO4
Crisaborole impurity 3
888967-63-3
C14H11NO2
Sitagliptin impurity 1
1345822-87-8
C16H19F5N5O5P
Sitagliptin impurity 2
1345822-86-7
C16H19F5N5O5P
Sitagliptin impurity 3
823817-58-9
C16H16F6N5O5P
Sitagliptin impurity 4
823817-57-8
C16H18F6N5O5P
Sitagliptin impurity 5
837430-15-6
C6H5F3N4O
Lesinurad sodium
1151516-14-1
C17H13BrN3O2S.Na
de-bromo Lesinurad
1533519-93-5
C17H15N3O2S
Benserazide HCl
2'-(2,3,4-Trihydroxybenzyl)-DL-serinohydrazidmonohydrochlorid
14919-77-8
C10H16ClN3O5
Benserazide P-1
1353749-74-2
C10H14ClN3O5
Silodosin P-1 oxalate
1883697-83-3
C27H32F3N3O7
Silodosin impurity 2
175870-21-0
C25H30F3N3O4
Rebamipide sodium salt
Rebamipide meta-Cl impurity
90098-05-8
C19H15ClN2O4
Roxatidine impurity 1
73279-04-6
C12H17NO
Roxatidine impurity 3
78274-00-7
C16H24N2O2
Roxatidine impurity 4
97900-87-3
C17H27ClN2O2
Elagolix impurity 1
2248628-93-3
C32H28F5N3O4
Elagolix impurity 3
2375499-61-7
C32H31F4N3O5
Erdosteine
84611-23-4
C8H11NO4S2
Ilaprazole
172152-36-2
C19H18N4O2S
Ilaprazole intermediate P-3
172152-53-3
C11H9N3S
Ilaprazole impurity 1
172152-37-3
C19H18N4O3S
Ilaprazole impurity 3
84445-90-9
C9H9N3OS
Ilaprazole impurity 4
1018229-53-2
C11H9N3O
Fexuprazan P-4
1902955-29-6
C13H11F2NO3
Fexuprazan P-1
1902955-31-0
C18H12F3NO4S
N-Bn Tegoprazan parent nucleus
1640981-20-9
C18H19N3O2
N-Ts Tegoprazan P-1
4942485-42-9
N-Bn Tegoprazan P-1
R-Tegoprazan isomer
942195-56-4
C20H19F2N3O3
Vonoprazan Fumarate
1260141-27-2
C21H20FN3O6S
Deoxycholic acid P-1
181270-68-8
C28H46O5
Deoxycholic acid impurity 1
Deoxycholic acid impurity 2
69519-35-3
C26H44O4
Deoxycholic acid impurity 3
Sodium Picosulfate impurity A
32500-19-9
C18H16NNaO5S
Diclofenac Epolamine impurity 4
127792-23-8
C14H11BrClNO2
Diclofenac Epolamine impurity 6
42088-52-8
C8H8N2
Diclofenac Epolamine impurity 7
172494-87-0
C13H11Cl2N
Pranoprofen P-2
146330-68-9
C15H12ClNO2
Pranoprofen impurity B
52549-22-1
C15H11NO3
Raloxifene HCl P-1
84541-36-6
C30H32ClNO4S
Raloxifene impurity 2
173773-26-7
C29H29NO4S.ClH
Glimepiride Cis isomer
684286-46-2
C24H34N4O5S
Glimepiride methyl ester
119018-30-3
C18H23N3O6S
Oseltamivir degradation impurity 1
Oseltamivir degradation impurity 2
1,1'-(4-(ethylamino)-6-hydroxy-1,3-phenylene)bis(ethan-1-one)
79324-49-5
C12H15NO3
Iodonitrotetrazolium chloride
2-(4-Iodophenyl)-3-(4-nitrophe-nyl)-5-phenyl-tetrazoliumchlorid
146-68-9
C19H13ClIN5O2
1,1'-(4-(allyloxy)-6-(ethylamino)-1,3-phenylene)bis(ethan-1-one)
79324-50-8
C15H19NO3
4-chloro-5-nitro-2-(propylthio)pyrimidine
2518331-26-3
C7H8ClN3O2S
1-isopropylpyrimidine-2,4,6(1H,3H,5H)-trione
69998-14-7
C7H10N2O3
Mavacamten MYK461 (S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione
1642288-47-8
C15H19N3O2
5-amino-2-(propylthio)pyrimidin-4-ol
1,1'-(4-(ethylamino)-6-hydroxy-5-propyl-1,3-phenylene)bis(ethan-1-one)
79324-51-9
C15H21NO3
6-chloro-3-isopropylpyrimidine-2,4(1H,3H)-dione
887581-47-7
C7H9ClN2O2
LCL161
1005342-46-0
C26H33FN4O3S
GDC-0276
1494581-70-2
C24H31FN2O4S
GSK-2110183C
1047644-62-1
C18H17Cl2FN4OS
Mefatinib
1417695-74-9
C21H19ClF3N5O2
GDC-0310 intermediate 1
1788072-29-6
C22H31ClFNO5
GDC-0310 intermediate 3
MK-1755 intermediate 4
955369-56-9
C17H19N5O2S
GDC-0310
1788063-52-4
C25H29Cl2FN2O4S
GDC-0310 intermediate 2
1788072-30-9
C25H36FNO5
Carbamic acid, N-?[(1S)?-?1-?cyclohexyl-?2-?[(2S)?-?2-?[4-?(4-?fluorobenzoyl)?-?2-?thiazolyl]?-?1-?pyrrolidinyl]?-?2-?oxoethyl]?-?, 1,?1-?dimethylethyl ester
1005342-80-2
C27H34FN3O4S
MK-1755 intermediate 2
2007908-48-5
C16H24N4O4S
MK-1755 intermediate 3
955368-90-8
C9H10N4OS
GDC-0310 intermediate 4
2448100-15-8
C25H28Cl2FNO3
JH-VIII-157-02
1639422-97-1
C28H27N5O2
GSK-2110183C impurity M14
(S)-(4-Fluorophenyl)(2-(pyrrolidin-2-yl)thiazol-4-yl)methanone hydrochloride
1263876-35-2
C14H14ClFN2OS
Testosterone Tridecanoate
488836-58-4
C32H52O3
GSK-2110183C intermediate
1047630-61-4
C9H6Cl2N2O2S
MK-1755 intermediate 1
21075-86-5
C8H16N2O2
Oxobutanedioic acid
Oxalessigsure
328-42-7
C4H4O5
L-Threonine, N-(4-ethynylbenzoyl)-, methyl ester
728878-24-8
C14H15NO4
4-aMino-3-Methoxy-N-(1-Methylpiperidin-4-yl)benzaMide
876126-60-2
C14H21N3O2
CHIR090
728865-23-4
C24H27N3O5
BI-2536 parent nucleus
755039-55-5
C14H19ClN4O
MK-1755
955365-80-7
C27H32N8O2
L-Threonine, N-[4-[2-[4-(4-morpholinylmethyl)phenyl]ethynyl]benzoyl]-, methyl ester
728878-12-4
C25H28N2O5
d-Mefatinib
GSK-2110183C impurity d-M14
4-methoxy-5-nitro-2-(propylthio)pyrimidine
2514951-26-7
C8H11N3O3S
1,1'-(4-amino-6-hydroxy-1,3-phenylene)bis(ethan-1-one)
79324-45-1
C10H11NO3
Diclofenac Epolamine impurity 2
13625-57-5
C13H9Cl2NO2
N-(2,4-diacetyl-5-hydroxyphenyl)acetamide
79324-44-0
C12H13NO4
Raloxifene impurity 1
84541-37-7
C29H29NO4S.ClH
1
2
3
Copyright 2019 ? ChemicalBook. All rights reserved